These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14533950)

  • 21. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice.
    Sankar R; Ramsay E; McKay A; Hulihan J; Wiegand F;
    Epilepsy Behav; 2009 Aug; 15(4):506-12. PubMed ID: 19643672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spotlight on topiramate in epilepsy.
    Lyseng-Williamson KA; Yang LP
    CNS Drugs; 2008; 22(2):171-4. PubMed ID: 18193927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spotlight on oxcarbazepine in epilepsy.
    Bang LM; Goa KL
    CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics and indications of topiramate].
    Nieto-Barrera M
    Rev Neurol; 2002 Sep; 35 Suppl 1():S88-95. PubMed ID: 12373660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of topiramate and its clinical value in epilepsy.
    Bai YF; Zeng C; Jia M; Xiao B
    Seizure; 2022 May; 98():51-56. PubMed ID: 35421622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
    Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability and safety of topiramate in Chinese patients with epilepsy : an open-label, long-term, prospective study.
    Lu Y; Wang X; Li Q; Li J; Yan Y
    Clin Drug Investig; 2007; 27(10):683-90. PubMed ID: 17803343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topiramate titration to response: analysis of individualized therapy study (TRAITS).
    Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC
    Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of the first antiepileptic drug in the treatment of pediatric epilepsy.
    Ma MS; Ding YX; Ying W; Fang F; Ding CH; Zou LP
    Pediatr Neurol; 2009 Jul; 41(1):22-6. PubMed ID: 19520269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topiramate Extended Release: A Review in Epilepsy.
    Hoy SM
    CNS Drugs; 2016 Jun; 30(6):559-66. PubMed ID: 27224993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a rapid action of levetiracetam compared to topiramate in refractory partial epilepsy.
    Specchio LM; Boero G; Specchio N; De Agazio G; De Palo A; de Tommaso M; Beghi E; La Neve A
    Seizure; 2006 Mar; 15(2):112-6. PubMed ID: 16406697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities.
    Singh BK; White-Scott S
    Seizure; 2002 Jan; 11(1):47-50. PubMed ID: 11888260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate: new indication. A bulkier assessment file.
    Prescrire Int; 1999 Oct; 8(43):141-2. PubMed ID: 11503838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate in add-on therapy: results from an open-label, observational study.
    Krakow K; Lengler U; Rettig K; Schreiner A; Schauble B;
    Seizure; 2007 Oct; 16(7):593-600. PubMed ID: 17543544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of topiramate in childhood absence epilepsy.
    Piña-Garza JE; Schwarzman L; Wiegand F; Hulihan J
    Acta Neurol Scand; 2011 Jan; 123(1):54-9. PubMed ID: 20219018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations.
    Pearl NZ; Babin CP; Catalano NT; Blake JC; Ahmadzadeh S; Shekoohi S; Kaye AD
    Adv Ther; 2023 Sep; 40(9):3626-3638. PubMed ID: 37368102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.